Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Cuts 72 Employees in Restructuring Effort

NEW YORK (GenomeWeb News) – PerkinElmer reduced its number of employees by 72 as part of a restructuring plan during its recently completed second quarter, the company disclosed this week.

In its form 10Q filed with the US Securities and Exchange Commission on Wednesday, the company said that during the second quarter, management approved a plan to shift resources to higher-growth geographies and end markets, and as part of that plan, it had trimmed its workforce by 72.

The restructuring plan resulted in workforce reductions in both its Human Health and Environmental Health segments, it said, though it did not provide further details.

In Human Health, PerkinElmer took a $2.2 million pre-tax restructuring charge related to the workforce reduction and the closure of excess facility space, it said. In Environmental Health, the headcount subtraction and facility space closure resulted in a pre-tax restructuring charge of $3.4 million.

All employees who are being terminated have been notified, and PerkinElmer expects the remaining severance payments of $4.8 million for workforce reductions will be completed by the end of 2012, it said.

Officials from the company did not respond to a request for comment.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.